Will Natazia Overcome the Health Risks Associated With Yaz?

The birth control method called Yaz has gotten a bad reputation, because the pill has been linked to an increased risk of blot clots and other harmful side effects. Pharmaceutical manufacturer Bayer is introducing a new form of birth control called Natazia, which it hopes will overcome the health risks associated with Yaz. The only trouble is that Natazia contains a form of estrogen that has never been used as an oral contraceptive before, so it is unclear what the long term effects of Natazia will be. According to NPR:

“The safest is still, surprisingly, one of the oldest pills,” says Dr. Frits Rosendaal, an expert in clotting disorders at Leiden University in Holland.

Rosendaal led another study that also found that women taking Yaz have a higher risk of clotting than those on older birth control pills — about twice as high. That paper also appeared in the British Medical Journal. [Read more...]

FDA Approves the First Four-Phase Oral Contraceptive to Hit U.S. Markets

In the midst of the birth control pills 50th birthday, the FDA has officially approved a brand new birth control option for American women. The pill, Natazia, was officially given the stamp of approval by the U.S. Food and Drug Administration on Thursday. Looks like Natazia has the same risks with the potential for less menstrual bleeding. Moreover, Natazia combines the hormones estrogen and progestin in doses that adjust four-times throughout a woman’s cycle.

The pill, already licensed in Europe under the brand name Qlaira, is the first four-phase oral contraceptive marketed in the United States, the FDA said.

It delivers varying doses of the hormones progestin at four times throughout each 28-day treatment cycle. [Read more...]